The second messenger of sphingomyelin signaling, ceramide, acts as an intracellular signal via phosphatase activation and protein kinase C (PKC) inhibition. We tested the hypothesis that ceramide may have an regulatory role in determining vascular tone. Natural ceramide was applied to phenylephrine precontracted aortic rings from Sprague-Dawley rats in an organ bath. In endothelium-intact aortic rings, concentrations of ceramide at 10^(-6) and 10^(-5) mole/L induced 24±6 and 52±7% relaxation, respectively. Removal of the endothelium significantly inhibited ceramide-induced relaxation to 13±5%(10^(-6)mole/L) and 29±5% (10^(-5)mole/L). Similar inhibition was observed in endothelium-intact aortic rings pretreated with N(superscript ω)-nitro-L-arginine (10^(-4)mole/L) or methylene blue (10^(-5)mole/L), suggestingthat endothelium-derived nitric oxide is involved in ceramide-induced relaxation. N-acetylsphingosine (C2-ceramide), N-hexanoylsphingosine (C6-ceramide), N-palmitoylsphingosine (C16-ceramide)and D-sphingosine all demonstrated dose-dependent relaxation responses in endothelium-intact vessels. Sphingomyelin signaling through the nitric oxide-dependent mechanism may have an important role in regulating vascular tone.